Conjugation of the photosensitizer Chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy
Source abstract
Abstract
To improve the cellular internalization and tumor-specific targeting efficiency of a photosensitizer, Chlorin e6 (Ce6), was conjugated to Pluronic F127(®) (PF127) by esterification between the carboxylic groups of Ce6 and the two hydroxyl groups of PF127 (PCe6). After conjugation, two different PCe6 conjugates, PF127/Ce6 (PCe6-1) and Ce6/PF127/Ce6 (PCe6-2), were obtained and separated by hydrophobic interaction chromatography. In this study, PCe6-1 was employed because it has good solubility in aqueous media. The singlet oxygen generation (SOG) efficiency and fluorescence activity of PCe6-1 in aqueous media dramatically increased compared to free Ce6. Moreover, confocal imaging and fluorescence-activated cell sorting (FACS) analysis confirmed its enhanced internalization rate in mouse colon tumor (CT-26) cells. After light irradiation, the cellular phototoxicity of PCe6-1 against CT-26 was approximately 3 times higher than that of free Ce6 in vitro. Furthermore, PCe6-1 exhibited enhanced tumor-specific distribution and tumor growth inhibition after intravenous injection into tumor-bearing mice. These results suggest that PCe6-1 is a good candidate as a photosensitizer due to its high cellular internalization rate and tumor targeting efficiency.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Photodynamic therapy10.1093/jnci/90.12.889 ↗
2. Photodynamic therapy for cancer10.1038/nrc1071 ↗
3. How does photodynamic therapy work?10.1111/j.1751-1097.1992.tb04222.x ↗
4. Photodynamic therapy (PDT) for lung cancers10.1016/S1556-0864(15)31616-6 ↗
5. A nano complex of hydrophilic phthalocyanine and polyethylenimine for improved cellular internalization efficiency and phototoxicity10.1016/j.colsurfb.2012.06.036 ↗
6. Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations10.1016/j.jphotobiol.2009.04.006 ↗
7. Nanoparticles as vehicles for delivery of photodynamic therapy agents10.1016/j.tibtech.2008.07.007 ↗
8. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system10.1016/j.biomaterials.2011.02.009 ↗
9. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy10.1039/cs9952400019 ↗
10. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs10.1016/j.addr.2003.12.004 ↗
11. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer10.1016/j.biomaterials.2013.01.010 ↗
12. Photodynamic efficacy of photosensitizers under an attenuated light dose via lipid nano-carrier-mediated nuclear targeting10.1016/j.biomaterials.2012.04.023 ↗
13. Liposomes for photodynamic therapy10.1016/j.addr.2003.07.014 ↗
14. Pegylation of a chlorine6 polymer conjugate increases tumor targeting of photosensitizer
15. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity10.1016/j.biomaterials.2005.05.028 ↗
16. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release10.1016/j.jconrel.2006.07.011 ↗
17. Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro10.1023/A:1015370532543 ↗
18. Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel10.1097/00001813-200104000-00003 ↗
19. The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher10.1016/j.biomaterials.2011.07.023 ↗
20. Oral drug absorption enhancement by chitosan and its derivatives10.1016/S0169-409X(01)00231-9 ↗
21. Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors10.1016/1011-1344(93)06974-8 ↗
22. High efficiency and low toxicity of polyethyleneimine modified pluronics (PEI-Pluronic) as gene delivery carriers in cell culture and dystrophic mdx mice10.1039/c2jm15625c ↗
23. Block copolymeric biotransport carriers as versatile vehicles for drug delivery10.1517/13543784.7.9.1453 ↗
24. Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: selective energy depletion10.1054/bjoc.2001.2165 ↗
25. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers10.1016/j.jconrel.2010.01.004 ↗
26. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers10.1023/A:1011964213024 ↗
27. Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer10.1021/bc025504w ↗
28. Pluronic® block copolymers: novel functional molecules for gene therapy10.1016/S0169-409X(02)00018-2 ↗
29. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery10.1016/S0168-3659(02)00009-3 ↗
30. Pluronic® block copolymers for overcoming drug resistance in cancer10.1016/S0169-409X(02)00047-9 ↗
31. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers10.1016/j.jconrel.2008.04.013 ↗
32. In vitro and in vivo efficacy of Photofrin® and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells10.1562/0031-8655(2002)075<0140:IVAIVE>2.0.CO;2 ↗
33. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects10.1021/bc100070g ↗
34. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer10.1021/ja801631c ↗
35. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy10.1016/j.biomaterials.2010.04.030 ↗
36. Determination of the singlet oxygen quantum yield of bacteriochlorin a: a comparative study in phosphate buffer and aqueous dispersion of dimiristoyl-L-α-phosphatidylcholine liposomes10.1039/b201081j ↗
37. Singlet oxygen generation by photodynamic agents10.1016/S1011-1344(96)07349-6 ↗
38. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice10.1016/j.biomaterials.2009.01.058 ↗
39. Drug release characteristics of PAMAM dendrimer–drug conjugates with different linkers10.1016/j.ijpharm.2009.10.017 ↗
40. Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates10.1021/bc0498018 ↗
41. Mechanisms of micellization and rheology of PEO–PPO–PEO triblock copolymers with various architectures10.1016/j.jcis.2008.09.029 ↗
42. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications10.1016/j.biomaterials.2009.06.004 ↗
43. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system10.1016/S0378-5173(99)00447-0 ↗
44. Critical importance of the triplet lifetime of photosensitizer in photodynamic therapy of tumor10.1111/j.1751-1097.1989.tb04167.x ↗
45. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo10.1016/S1011-1344(96)07291-0 ↗
46. Targeted nanodelivery of drugs and diagnostics10.1016/j.nantod.2010.03.003 ↗